Virbac

Virbac Liabilities

The The Liabilities of Virbac (VIRP.PA) as of Oct 30, 2026 is 789.19 M EUR. In the previous year, The Liabilities was 805.12 M EUR — a change of -1.98% (lower).

Liabilities

789.19 MEUR

YoY

-1.98%

Last updated:

In 2025, Virbac's total liabilities amounted to 789.19 M EUR, a -1.98% difference from the 805.12 M EUR total liabilities in the previous year.

The Virbac Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
776.93 M EUR
Jan 1, 2019
771.38 M EUR
Jan 1, 2020
454.28 M EUR
Jan 1, 2021
498.84 M EUR
Jan 1, 2022
521.17 M EUR
Jan 1, 2023
545.81 M EUR
Jan 1, 2024
805.12 M EUR
Jan 1, 2025
789.19 M EUR
The Virbac Liabilities history
YEARLiabilitiesYoY
789.19 MEUR-1.98%
805.12 MEUR+47.51%
545.81 MEUR+4.73%
521.17 MEUR+4.48%
498.84 MEUR+9.81%
454.28 MEUR-41.11%
771.38 MEUR-0.71%
776.93 MEUR-2.70%
798.49 MEUR-10.92%
896.37 MEUR-5.47%
948.26 MEUR+12.40%
843.65 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Virbac Stock analysis

What does Virbac do? Virbac SA is a French company specializing in animal medicines and care products. The company was founded in 1968 by Pierre Richard Dick, who studied veterinary medicine at the École nationale vétérinaire d'Alfort and gained experience as a veterinarian. Since its founding, Virbac SA has been headquartered near Carros, France and operates worldwide. The business model of Virbac SA is to offer a wide range of products to veterinarians and pet owners, aiming to ensure optimal health, care, and quality of life for their pets. This includes everything from vaccines, diagnostics, and medications to grooming products that veterinarians and pet owners need to ensure optimal pet healthcare. Virbac SA has five main business areas, namely livestock, pets, horses, hygiene products, and specialties. The livestock sector includes products such as feed additives and antiparasitics tailored to the specific needs of cattle, pigs, poultry, and fish. In the pets sector, Virbac SA offers products specifically tailored to dogs, cats, birds, and other pets. This includes both disease prevention and treatment products. In the horse sector, the company offers products for the maintenance, care, and health of horses. Another division of Virbac SA is hygiene products. The company offers a wide portfolio of products and solutions that support both veterinarians and pet owners in ensuring the health and care of animals. This ranges from infection control products to animal-specific shampoos and grooming items. The specialties sector, on the other hand, includes specialized products such as targeted diagnostics, therapeutics, and dietary supplements. The constant focus on research and development also leads to innovative product launches that consistently meet the highest quality standards. An example of this is the scientifically developed dental hygiene product line that improves both the oral health and breath quality of dogs and cats. For this, Virbac SA also receives awards from the Veterinary Center for Clinical Medicine in Munich. Through a systematic international expansion strategy, Virbac SA is now present in more than 100 countries. The company employs over 4,800 people worldwide and achieved a turnover of 954 million euros in 2019. Overall, Virbac SA stands for consistently high product quality and a strong customer orientation. With a combination of expertise and extensive scientific research and development, particularly in the field of animal health and care, the company is an important player in the global animal medicine manufacturing market. Virbac is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Virbac's Liabilities

Virbac's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Virbac's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Virbac's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Virbac's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Virbac’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Virbac stock

The Liabilities of Virbac is 789.19 M EUR in 2025.

The Liabilities of Virbac changed from 805.12 M EUR to 789.19 M EUR, representing a -1.98% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Virbac since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Virbac historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Virbac

All Key Metrics — Virbac